Funder: Breakthrough T1D
Due Dates (Anticipated): October 24, 2025 (Proposal Submission) | January 2026 (Response) | March 2026 (Earliest Start)
Funding Amounts: Up to $200,000 (including 10% indirects) for 1 year; not renewable.
Summary: Seed funding for bold, high-risk/high-reward research with potential for major advances in type 1 diabetes (T1D).
Key Information: No preliminary data required; open to global applicants from eligible research institutions.